RenovoRx, Inc. is a life sciences company developing targeted oncology therapies and commercializing RenovoCath, an FDA-cleared local drug-delivery device. Its patented Trans-Arterial Micro-Perfusion (TAMP) platform enables intra-arterial delivery of therapeutic agents near tumor sites. The company is conducting a Phase III trial (TIGeR-PaC) evaluating intra-arterial gemcitabine (IAG) for pancreatic cancer and generated $1.1 million in revenue from RenovoCath sales for the year ended December 31, 2025.
expected 2026-11-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001193125-26-131928 | EDGAR | 80K words |
| 2025-04-01 | 2024-12-31 | 0001641172-25-001932 | EDGAR | 84K words |
| 2024-04-01 | 2023-12-31 | 0001493152-24-012357 | EDGAR | 95K words |
| 2023-03-31 | 2022-12-31 | 0001493152-23-010332 | EDGAR | — |
| 2022-03-30 | 2021-12-31 | 0001493152-22-008080 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-13 | 2026-06-30 | 0001193125-26-349190 | EDGAR | 25K words |
| 2025-11-13 | 2025-09-30 | 0001493152-25-022304 | EDGAR | 28K words |
| 2025-08-14 | 2025-06-30 | 0001641172-25-024020 | EDGAR | 27K words |
| 2025-05-15 | 2025-03-31 | 0001641172-25-010935 | EDGAR | 23K words |
| 2024-11-13 | 2024-09-30 | 0001493152-24-045137 | EDGAR | 26K words |
| 2024-08-13 | 2024-06-30 | 0001493152-24-031675 | EDGAR | 23K words |
| 2024-05-10 | 2024-03-31 | 0001493152-24-018704 | EDGAR | 20K words |
| 2023-11-13 | 2023-09-30 | 0001493152-23-040598 | EDGAR | 53K words |
| 2023-08-16 | 2023-06-30 | 0001493152-23-029125 | EDGAR | 52K words |
| 2023-05-12 | 2023-03-31 | 0001493152-23-016648 | EDGAR | 48K words |
| 2022-11-14 | 2022-09-30 | 0001493152-22-031491 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001493152-22-022384 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-20 | 0001493152-26-039472 | EDGAR | 1K words |
| 2026-08-12 | 0001193125-26-346894 | EDGAR | 5K words |
| 2026-08-04 | 0001493152-26-035995 | EDGAR | 2K words |
| 2026-03-30 | 0001493152-26-013653 | EDGAR | 4K words |
| 2026-03-27 | 0001493152-26-013080 | EDGAR | 2K words |
| 2026-03-23 | 0001493152-26-012058 | EDGAR | 2K words |
| 2026-02-06 | 0001493152-26-005437 | EDGAR | 2K words |
| 2026-01-02 | 0001493152-26-000113 | EDGAR | 1K words |
| 2025-11-14 | 0001493152-25-023604 | EDGAR | 23K words |
| 2025-11-13 | 0001493152-25-022325 | EDGAR | 3K words |
92 total filings indexed. 65 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001574094 |
| Ticker | RNXT |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.renovorx.com |
| Listed | 2021-08-26 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/RNXT (~200 tokens, structured JSON with cryptographic provenance)